We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-11.74%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$95.9M
AUM Growth
-$7.63M
(-7.4%)
Cap. Flow
+$3.79M
Cap. Flow
% of AUM
3.95%
Top 10 Holdings %
Top 10 Hldgs %
62.51%
Holding
48
New
11
Increased
11
Reduced
6
Closed
9
Top Buys
| 1 |
GSK
GSK
|
+$7.15M |
| 2 |
Edwards Lifesciences
EW
|
+$5.35M |
| 3 |
Zimmer Biomet
ZBH
|
+$5.16M |
| 4 |
Eli Lilly
LLY
|
+$4.99M |
| 5 |
Aclaris Therapeutics
ACRS
|
+$3.53M |
Top Sells
| 1 |
Sanofi
SNY
|
+$8.8M |
| 2 |
Philips
PHG
|
+$7.46M |
| 3 |
Cardinal Health
CAH
|
+$4.7M |
| 4 |
Medpace
MEDP
|
+$3.46M |
| 5 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
+$2.84M |
Sector Composition
| 1 | Healthcare | 78.11% |
| 2 | Industrials | 6.06% |
| 3 | Financials | 2.59% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $10.8M | 11.29% |
55,944
+1,302
| +2% | +$282K |
|
|
2
GSK
GSK
$103B
| $6.96M | 7.26% |
+144,649
| New | +$7.15M |
|
|
3
Philips
PHG
$25.3B
| $6.4M | 6.68% |
282,945
-341,907
| -55% | -$7.46M |
|
|
HRC
4
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $5.98M | 6.24% |
106,594
+45,295
| +74% | +$2.57M |
|
|
TRHC
5
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $5.81M | 6.06% |
388,054
-121,946
| -24% | -$1.56M |
|
|
6
Edwards Lifesciences
EW
$51.9B
| $5.15M | 5.37% |
+165,000
| New | +$5.35M |
|
|
7
Cardinal Health
CAH
$53.9B
| $4.96M | 5.17% |
68,885
-65,052
| -49% | -$4.7M |
|
|
8
Eli Lilly
LLY
$1.03T
| $4.93M | 5.14% |
+67,000
| New | +$4.99M |
|
|
9
Zimmer Biomet
ZBH
$17.6B
| $4.82M | 5.03% |
+48,125
| New | +$5.16M |
|
|
AAAP
10
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $4.1M | 4.28% |
153,332
+77,775
| +103% | +$2.61M |
|
|
11
Aclaris Therapeutics
ACRS
$758M
| $3.76M | 3.92% |
+138,441
| New | +$3.53M |
|
|
DMK
12
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $3.31M | 3.45% |
15,015
+5,508
| +58% | +$1.1M |
|
|
NTUS
13
DELISTED
Natus Medical Inc
NTUS
| $3.16M | 3.3% |
90,865
+34,865
| +62% | +$1.37M |
|
14
Rigel Pharmaceuticals
RIGL
$762M
| $3.01M | 3.13% |
126,339
+24,267
| +24% | +$695K |
|
15
UnitedHealth
UNH
$386B
| $2.59M | 2.7% |
16,187
+1,138
| +8% | +$170K |
|
|
AET
16
DELISTED
Aetna Inc
AET
| $2.48M | 2.59% |
+20,000
| New | +$2.39M |
|
17
Boston Scientific
BSX
$63.4B
| $2.46M | 2.56% |
+113,500
| New | +$2.48M |
|
18
Perrigo
PRGO
$1.37B
| $2.44M | 2.54% |
29,329
-9,624
| -25% | -$835K |
|
|
CCXI
19
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.41M | 2.51% |
325,250
-288,640
| -47% | -$2.08M |
|
20
Amgen
AMGN
$192B
| $2.4M | 2.5% |
+16,430
| New | +$2.47M |
|
|
IMMU
21
DELISTED
Immunomedics Inc
IMMU
| $1.86M | 1.94% |
+506,978
| New | +$1.5M |
|
22
Actinium Pharmaceuticals
ATNM
$28.1M
| $1.44M | 1.5% |
54,969
+1,636
| +3% | +$51.2K |
|
|
ADMS
23
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.17M | 1.22% |
69,215
+3,105
| +5% | +$48K |
|
|
AVDL
24
DELISTED
Avadel Pharmaceuticals
AVDL
| $950K | 0.99% |
+91,413
| New | +$1M |
|
25
Spyre Therapeutics
SYRE
$8.59B
| $820K | 0.85% |
7,539
+1,366
| +22% | +$199K |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA